243 studies found for:    Exclude Unknown | Expanded Access Studies
Show Display Options
Rank Status Study
1 Available Effect of American Ginseng on Exercise-induced Muscle Soreness
Condition: Exercise-induced Muscle Soreness
Intervention: Dietary Supplement: Ginseng
2 Available GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
Condition: Obesity
Intervention: Drug: Liraglutide
3 Available Expanded Access WR 279396 Topical Cream Treatment for Uncomplicated Cutaneous Leishmaniasis
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: WR 279,396
4 Available Influence of Preoperative Enema Application on Return of Gastrointestinal Function After Elective Cesarean Section: A Randomized Controlled Study
Conditions: Postoperative Bowel Sounds;   Bowel Gass Passage
Intervention: Drug: Fleet enema
5 Available Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
Conditions: Recurrent Neuroblastoma;   Neuroblastoma
Interventions: Drug: Fenretinide Lym-X-Sorb Oral Powder;   Drug: Ketoconazole
6 No longer available An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada
Condition: HIV Infection
Intervention: Drug: Efavirenz
7 No longer available Compassionate Use of Defibrotide for Patients With Veno-occlusive Disease of the Liver
Condition: Hepatic Veno-occlusive Disease
Intervention: Drug: Defibrotide
8 No longer available Prochymal® Expanded Access for Adults Who Have Failed Steroid Treatment for Acute GVHD
Condition: Graft-Versus-Host Disease
Intervention: Drug: Prochymal®
9 No longer available Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) With 3, 4 DAP
Condition: Lambert Eaton Myasthenic Syndrome (LEMS)
Intervention: Drug: 3,4-diaminopyridine
10 No longer available Expanded Access Trial of Belimumab Antibody in RA Patients Who Were Previously Treated Under HGS Protocol LBRA99
Condition: Rheumatoid Arthritis
Intervention: Drug: belimumab
11 Available Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C
Interventions: Drug: Telaprevir + peginterferon alfa + ribavirin;   Drug: peginterferon alfa + ribavirin
12 Available Ocular Fluorophotometry for Glaucoma Treated With Cyclo-coagulation Using High Intensity Focused Ultrasound (HIFU).
Condition: Refractory Open Angle Glaucoma
Intervention: Procedure: high intensity focused ultrasound for cyclodestruction in the eye
13 Available Compassionate Use of Triclabendazole for the Treatment of Parasites (Prior to FDA Approval; Expanded Access Program)
Condition: Parasitic Disease
Intervention: Drug: Triclabendazole
14 No longer available Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Condition: West Nile Virus Infection
Intervention: Biological: MGAWN1
15 Available Safety and Efficacy of CG0070 Oncolytic Virus Regimen in Patients With High Grade Non-Muscle Invasive Bladder Cancer
Conditions: Bladder Cancer;   High Grade;   Non Muscle Invasive
Intervention: Biological: oncolytic adenovirus expressing GMCSF
16 Available Compassionate Use of Triheptanoin (C7) for Fatty Acid Oxidation Disorders and Glycogen Storage Disease
Conditions: Very Long-chain acylCoA Dehydrogenase (VLCAD) Deficiency;   Carnitine Palmitoyltransferase Deficiencies (CPT1, CPT2);   Mitochondrial Trifunctional Protein Deficiency;   Long-chain Hydroxyacyl-CoA Dehydrogenase Deficiency;   Glycogen Storage Disorders;   Pyruvate Carboxylase Deficiency, Type B;   Acyl-coA Dehydrogenase, Type 9
Intervention: Drug: triheptanoin
17 Approved for marketing Comparison of Biodegradable and Titanium Fixation Systems in Mandibular Symphysis or Parasymphysis Solitary Fractures
Conditions: Mandible Fracture;   Rigid Internal Fixation;   Three-dimensional Finite Element
Intervention: Other: Biodegradable and titanium fixation used in mandibular fractures.
18 No longer available Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer
Conditions: Carcinoma, Hepatocellular;   Neoplasm Metastasis
Intervention: Device: yttrium Y 90 microspheres (Therasphere®)
19 Available Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
Condition: Advanced Breast Cancer (Female)
Interventions: Drug: Palbociclib;   Drug: Letrozole
20 No longer available Compassionate Use Ponatinib
Conditions: Philadelphia Chromosome Positive (Ph+) Leukemias;   Chronic Myeloid Leukemia
Intervention: Drug: Ponatinib

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years